Kanki Keita

カンキケイタ | Kanki Keita

Affiliation and department：
Job title：准教授

Research field (2)： Biomaterials , Tumor biology

Research keywords (3)： regenerative medicine , cancer , cell differentiation

Research theme for competitive and other funds (10)：

2022 - 2025 細胞死抑制技術によるハイバイアビリティ細胞凝集体の創製と組織工学への応用
2018 - 2021 立体臓器チップ構築に向けた細胞単層の自動3D化技術の基盤開発
2018 - 2021 Development of anti-cancer strategy using IDH gene activation
2014 - 2016 Gene expression analysis of tumor-antigen PRAME in hepatocellular carcinoma and its possible involvement in tumor progression
2013 - 2015 Enhancing effect of retinoids on anti-cancerous drugs by regulating intracellular molecules

Show all

Papers (45)：

Takuro Matsumura, Yasuharu Ohta, Akihiko Taguchi, Syunsuke Hiroshige, Yasuko Kajimura, Naofumi Fukuda, Kaoru Yamamoto, Hiroko Nakabayashi, Ruriko Fujimoto, Akie Yanai, et al. Liver-specific dysregulation of clock-controlled output signal impairs energy metabolism in liver and muscle. Biochemical and biophysical research communications. 2021. 534. 415-421
Keita Kanki, Ryota Watanabe, Le Nguyen Thai, Chun-Hao Zhao, Kyoko Naito. HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth. Cancers. 2020. 12. 10
Kyoko Naito, Keita Kanki. Glycolytic inhibition by resveratrol prevents myoblast cell death caused by glucose deprivation and hypoxia; a possible application to the three-dimensional tissue construction. Journal of bioscience and bioengineering. 2020
Kensuke Harada, Ryuya Ohashi, Kyoko Naito, Keita Kanki. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling. International journal of molecular sciences. 2020. 21. 9
Xian-Yang Qin, Harukazu Suzuki, Masao Honda, Hikari Okada, Shuichi Kaneko, Ikuyo Inoue, Etsuko Ebisui, Kosuke Hashimoto, Piero Carninci, Keita Kanki, et al. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proceedings of the National Academy of Sciences of the United States of America. 2018. 115. 19. 4969-4974

ｍore...

MISC (1)：

Goshi Shiota, Hiroki Shimizu, Keita Kanki. Suppression of glycolysis by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib via AMPK activation. CANCER RESEARCH. 2015. 75

Professional career (1)：

Work history (7)：

2015/04 - 現在 Okayama University of Science Faculty of Engineering, Department of Biomedical Engineering Associate professor
2010/04 - 2015/03 Tottori University Graduate School of Medical Sciences Major in Regenerative Medicine and Biofunction Assistant Professor
2009/04 - 2010/03 Institute of Medical Science, the University of Tokyo Laboratory Animal Research Center Postdoctoral Researcher
2006/05 - 2009/03 Musashino University Research Institute of Pharmacy Postdoctoral Researcher
2006/01 - 2006/03 National Institute of Health Sciences Division of Medical Safety Science Postdoctoral Researcher

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page